These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6111433)

  • 1. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1981; 9(1):54-9. PubMed ID: 6111433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitative disposition of 3-O-methyl-(+)-[U-14C]catechin in man following oral administration.
    Hackett AM; Griffiths LA; Wermeille M
    Xenobiotica; 1985 Nov; 15(11):907-14. PubMed ID: 4082631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat.
    Hackett AM; Griffiths LA
    Drug Metab Dispos; 1983; 11(6):602-6. PubMed ID: 6140147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration.
    Hackett AM; Griffiths LA; Broillet A; Wermeille M
    Xenobiotica; 1983 May; 13(5):279-86. PubMed ID: 6636824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat.
    Okushio K; Suzuki M; Matsumoto N; Nanjo F; Hara Y
    Drug Metab Dispos; 1999 Feb; 27(2):309-16. PubMed ID: 9929521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration.
    Hackett AM; Griffiths LA
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):35-42. PubMed ID: 6407839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism and excretion of 3-palmitoyl-(+)-catechin in the rat.
    Hackett AM; Griffiths LA
    Xenobiotica; 1982 Jul; 12(7):447-56. PubMed ID: 6815903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.
    Aimoto T; Ito O; Kimura R; Murata T; Ito K
    Xenobiotica; 1979 Mar; 9(3):173-80. PubMed ID: 473792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.
    Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP
    Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of 14C-tiropramide after single intravenous or peroral administration to the rat.
    Setnikar I; Makovec F; Chistè R; Giachetti C; Zanolo G
    Arzneimittelforschung; 1989 Mar; 39(3):328-34. PubMed ID: 2757659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of dobutamine in the dog.
    Murphy PJ; Williams TL; Kau DL
    J Pharmacol Exp Ther; 1976 Nov; 199(2):423-31. PubMed ID: 978494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of (+)-catechin and some of its C-6 and C-8 substituted derivatives in the isolated perfused pig liver.
    van der Merwe PJ; Hundt HK
    Xenobiotica; 1984 Oct; 14(10):795-802. PubMed ID: 6506752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.